Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Assessed listed medicines (26)
- Advertising (248)
- Medicine safety (161)
- COVID-19 (144)
- Prescription medicines (142)
- Regulatory compliance (128)
- COVID-19 vaccines (88)
- Legislation (81)
- Therapeutic goods regulation (75)
- Listed medicines (54)
- Non-prescription medicines (50)
- Safety (48)
- Medical devices safety (43)
- Vaping hub (39)
- Manufacturing (34)
- Complementary medicines (33)
- Labelling and packaging (29)
- Over the counter (OTC) medicines (25)
- Scheduling (national classification system) (24)
- Australian Register of Therapeutic Goods (ARTG) (22)
- Compliance and enforcement hub (22)
- Medicinal cannabis hub (21)
- Import and export (19)
- Alert/Advisory (18)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (8)
- Weight loss products (8)
- Advisory bodies and committees (5)
- Clinical trials (3)
- Cosmetics (3)
- Blood and blood components (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Registered complementary medicines (2)
- Unique Device Identification (UDI) hub (2)
- Advanced therapies (1)
- Biological medicines (1)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Search
26 result(s) found, displaying 1 to 25
-
NewsWe will be initiating targeted compliance reviews of selected listed medicines that are required to display a warning statement
-
NoticesListed medicines indications and requirements for their use have been updated in the Therapeutic Goods (Permissible Indications) Determination (No. 1) 2025.
-
NewsThe Assessed listed medicine evidence guidelines have been updated, based on feedback, to aid sponsors in preparing their product applications.
-
NoticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2023.
-
NewsNew guidelines and mandatory requirements for listed medicines ingredients have come into effect on 1 February 2023.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 5) 2022.
-
NewsThe Pharmacovigilance Inspection Program (PVIP) Risk Assessment Survey is now open until 18 December 2022 for medicine sponsors to complete.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2022.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2022.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commences on 1 March 2022.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commenced on 18 January 2022.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commenced on 25 October 2021.
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
NoticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Media releasesToday the TGA announced a final decision to down-schedule certain low dose cannabidiol (CBD) preparations
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
BlogHow to find information about the inactive ingredients in your medicines.
-
NoticesListed medicine ingredients and requirements have been updated.
-
NoticesThe Permissible Ingredients Determination has been updated.
-
NoticesThe Permissible Ingredients Determination has been updated.
-
NoticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
NoticesAn amendment to the Therapeutic Goods (Permissible Ingredients) Determination commenced on 2 September 2019.